Transcriptomic analysis reveals TME-mediated macrophage IFIT1 upregulation and CX3CR1 suppression drive osteosarcoma

Keyi Wang1, Huanyang He1, Jiamin Liang1

  • 1Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Department of Orthopedics Trauma and Hand Surgery, Guangxi Key Laboratory of Regenerative Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Frontiers in Oncology
|November 21, 2025
PubMed
Abstract

Insights

Osteosarcoma tumor microenvironment alters macrophage gene expression. Upregulating IFIT1 and downregulating CX3CR1 accelerates osteosarcoma progression, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Osteosarcoma (OS) is a prevalent bone tumor with poor patient prognosis.
  • Conventional treatments for OS have stagnated, prompting research into novel therapeutic targets.
  • The tumor microenvironment (TME) and tumor-associated macrophages (TAM) are emerging as key areas of investigation.

Purpose of the Study:

  • To investigate how the OS TME influences macrophage gene expression.
  • To identify potential therapeutic targets within the OS TME for improved treatment strategies.

Main Methods:

  • Bone marrow-derived macrophages (BMMs) were cultured with K7M2 conditional medium (CM) to analyze gene expression changes via RNA sequencing.
  • Single-cell sequencing and PCR were employed to assess IFIT1 and CX3CR1 expression levels.
  • Functional validation was conducted using flow cytometry, cloning, wound healing, and transwell assays with specific inhibitors.

Main Results:

  • Exposure to OS TME altered BMM morphology and transcriptome, revealing complex interactions among differentially expressed genes.
  • A representative finding was the upregulation of IFIT1 and downregulation of CX3CR1.
  • Inhibiting CX3CR1 promoted TAM polarization and accelerated osteosarcoma progression; increasing IFIT1 also enhanced osteosarcoma growth.

Conclusions:

  • The OS TME significantly modifies macrophage gene expression.
  • These findings provide a cellular and molecular basis for exploring novel therapeutic targets in osteosarcoma treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K